Figure 1From: Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program Schematic diagram of the markov model. Each thalassemia patient has two treatment options (RI-HSCT and BT-ICT) The Markov model consists of eight health states and patients receiving RI-HSCT can transition through each of these health states whereas BT-ICT patients can be in either alive BT-ICT state or death state. The cycle length is one year with a 99-year time horizon. RI-HSCT: Reduced intensity hematopoietic stem cell transplantation; BT-ICT: Blood transfusion combined with iron chelating therapy.Back to article page